Recruiting

Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Code:

NCT00004317

Conditions

Toxoplasmosis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Leucovorin calcium

Pyrimethamine

Spiramycin

Sulfadiazine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information